# Clinical Program Manager - Regional & Vendor Oversight at Akero Therapeutics

> Remote · region unclear · Unspecified · Other · open. Source: https://alderhq.app/jobs/greenhouse%3Aakerotherapeutics%3A4747956005 (read 2026-11-20).

## Facts (observed)

- Company: [Akero Therapeutics](https://alderhq.app/companies/akero-therapeutics)
- Location text: Remote; Headquarters
- Where it can be done from (inferred): Remote · region unclear (evidence: "Location: Remote; Headquarters")
- Posted: 2026-10-27 (24 days ago)
- First seen by alder: 2026-11-04 · last verified: 2026-11-10
- Reposted: 0 times · edited: 0 times
- Apply on the employer's site: https://job-boards.greenhouse.io/akerotherapeutics/jobs/4747956005
- Skills listed (inferred): GCP

## Pay and sponsorship

- Posted pay: not posted

## Description (the employer's text)

### COMPANY BACKGROUND

Akero Therapeutics, a Novo Nordisk company, is a clinical stage biopharmaceutical company focused on discovering and developing transformational treatments for patients with serious metabolic diseases marked by high unmet need. Our current focus is on advancing our lead program efruxifermin (EFX) to provide a powerful new treatment for patients with MASH(metabolic dysfunction-associated steatohepatitis).

We are a team of problem solvers dedicated to pursuing bold scientific approaches to build a brighter future for patients. Our diverse skill sets and backgrounds, desire to learn from each other and collaborative spirit breed a culture where everyone feels inspired to bring their best thinking to work, and to bring out the best in others.

### Purpose

Akero Therapeutics is developing medicines that deliver transformational outcomes to patients with serious metabolic diseases. Our lead clinical program, Efruxifermin (EFX), is a treatment for non-alcoholic steatohepatitis (NASH), rapidly emerging as the leading cause of liver disease around the world. Efruxifermin is a novel long-acting fibroblast growth factor 21 (FGF21) agonist, with the potential to substantially improve the lives of patients with NASH, and other serious metabolic diseases.

We are a team of problem solvers dedicated to pursuing bold scientific approaches to build a brighter future for patients. Our diverse skill sets and backgrounds, desire to learn from each other and collaborative spirit breed a culture where everyone feels inspired to bring their best thinking to work, and to bring out the best in others.

The Clinical Program Manager (CPM) is a key member of Clinical Operations and will closely partner with the Senior Director of Clinical Program Management. The CPM will serve as the Global Study Lead for a large, global Phase 3 clinical study within a Phase 3 program, with accountability for the operational planning, execution, oversight, and delivery of the study.

### Relationships

Reporting to the Senior Director, Clinical Program Management

The position will interact with all areas of Clinical. In addition, clinical within Novo Nordisk. The position interacts with team members at the IC through Vice President level. The position requires experience interacting with senior level positions in each of these departments and a good understanding of how these peer teams operate, ideally through experience working within these teams (broad experience).

Externally, the position will engage with CROs. For CROs it will be at the Scientist level.

### Essential Functions

- Provide Clinical Operations oversight across assigned regions, CROs, and vendors within a large, global Phase 3 program, ensuring consistent execution against study plans, timelines, quality expectations, and regulatory requirements.
- Partner closely with Global Study Leads, regional teams, CROs, and vendors to monitor study performance, identify operational risks and trends, and drive timely resolution of issues.
- Provide oversight of regional study execution, including site start-up, enrollment, monitoring, site performance, and ongoing study conduct.
- Monitor CRO and vendor performance, study metrics, and operational trends; identify risks and gaps and drive timely mitigation, escalation, and corrective actions
- Analyze study metrics and operational trends across regions and vendors to identify areas requiring additional oversight, escalation, or mitigation.
- Support inspection and audit readiness activities, including assessment of study documentation, identification and remediation of gaps, and coordination of readiness activities with internal teams, CROs, vendors, and study sites.
- Ensure study activities and documentation comply with applicable regulations, ICH-GCP, SOPs, and study-specific plans.
- Partner with cross-functional stakeholders, including Clinical Research, Data Management, Biostatistics, Regulatory, and Quality, to support successful program execution.
- Provide regular updates on regional and vendor performance, key risks, and inspection readiness to Clinical Operations leadership and study teams.

---
Data: alder (https://alderhq.app). Cite https://alderhq.app/jobs/greenhouse%3Aakerotherapeutics%3A4747956005 and the date you read it. Observed facts come from the employer's own listing; location reach, level, family and skills are inferences.
